Total polyphenol of Anemarrhena asphodeloides ameliorates advanced glycation end products-induced endothelial dysfunction by regulation of AMP-Kinase

Journal of Diabetes

Volumn 6, Issue 4, 2014, Pages 304-315

  Zhao, Qianwen ^a   Sun, Yan ^a   Ji, Yu ^a   Xu, Lihua ^b   Liu, Kang ^a   Liu, Baolin ^a   Huang, Fang ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SUZHOU UNIVERSITY   (China)

Author keywords

Advanced glycation end products; AMP Kinase; Endothelial dysfunction; Total polyphenol of Anemarrhena asphodeloides

Indexed keywords

ADENYLATE KINASE; ADVANCED GLYCATION END PRODUCT; ANEMARRHENA ASPHODELOIDES EXTRACT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; POLYPHENOL; REACTIVE OXYGEN METABOLITE; SYNAPTOTAGMIN I; MESSENGER RNA;

ANEMARRHENA ASPHODELOIDES; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MITOCHONDRIAL MEMBRANE POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ANEMARRHENA; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; CHINA; CYTOLOGY; DRUG EFFECTS; GENETICS; METABOLISM; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ADENYLATE KINASE; ANEMARRHENA; BLOTTING, WESTERN; CELL SURVIVAL; CELLS, CULTURED; CHINA; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, FLUORESCENCE; NITRIC OXIDE; PHOSPHORYLATION; POLYPHENOLS; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 84901840018     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12111     Document Type: Article

References (35)

1. McVeigh GE, Brennan GM, Johnston GD etal. Impaired endothelium dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992; 35: 771-776.
2. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: A clinical perspective. Endocr Rev. 2001; 22: 36-52.
3. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Eur Heart J. 2013; 34: 2436-2443.
4. Hartge MM, Kintscher U, Unger T. Endothelial dysfunction and its role in diabetic vascular disease. Endocrinol Metab Clin North Am. 2006; 35: 551-560.
5. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988; 318: 1315-1321.
6. Win MT, Yamamoto Y, Munesue S etal. Regulation of RAGE for attenuating progression of diabetic vascular complications. Exp Diabetes Res. 2012; 2012: 894605.
7. Yamaqishi S. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol. 2011; 46: 217-224.
8. Lin N, Zhang H, Su Q. Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress. Diabetes Metab. 2012; 38: 250-257.
9. Negre-Salvayre A, Salvayre R, Augé N etal. Hyperglycemia and glycation in diabetic complications. Antioxid Redox Signal. 2009; 11: 3071-3109.
10. Guo ZJ, Niu HX, Hou FF etal. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal. 2008; 10: 1699-1712.
11. Sena CM, Matafome P, Crisostomo J etal. Methylglyoxal promotes oxidative stress and endothelial dysfunction. Pharmacol Res. 2012; 65: 497-506.
12. Daroux M, Prévost G, Maillard-Lefebvre H etal. Advanced glycation end-products: Implications for diabetic and non-diabetic nephropathies. Diabetes Metab. 2010; 36: 1-10.
13. Davis BJ, Xie Z, Viollet B, Zou MH. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes. 2006; 55: 496-505.
14. Kim JA, Formoso G, Li Y etal. Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem. 2007; 282: 13-736.
15. Yang Z, Kahn BB, Shi H, Xue BZ. Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J Biol Chem. 2010; 285: 19-051.
16. Galic S, Fullerton MD, Schertzer JD etal. Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J Clin Invest. 2011; 121: 4903-4915.
17. Lihn AS, Pedersen SB, Lund S, Richelsen B. The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol Cell Endocrinol. 2008; 292: 36-41.
18. Reiter CE, Kim JA, Quon MJ. Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: Roles for AMP-activated protein kinase, Akt, and FOXO1. Endocrinology. 2010; 151: 103-114.
19. Schuhmacher S, Foretz M, Knorr M etal. α1AMP-activated protein kinase preserves endothelial function during chronic angiotensin II treatment by limiting Nox2 upregulation. Arterioscler Thromb Vasc Biol. 2011; 31: 560-566.
20. Xie W, Zhao Y, Zhang Y. Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus. Evid Based Complement Alternat Med. 2011; 2011: 726723.
21. Xu LL, Wang L, Wang YQ. Effects of radix salviae miltiorrhiae, radix aconiti lateralis preparata and rhizoma anemarrhena on nitric oxide systems of endotoxemia mice. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2006; 26: 102-107.
22. Lu WQ, Qiu Y, Li TJ, Tao X, Sun LN, Chen WS. Antiplatelet and antithrombotic activities of timosaponin B-II, an extract of Anemarrhena asphodeloides. Clin Exp Pharmacol Physiol. 2011; 38: 430-434.
23. Miura T, Ichiki H, Hashimoto I etal. Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine. 2001; 8: 85-87.
24. Prabhu S, Jainu M, Sabitha KE, Shyamala Devi CS. Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats. Vascul Pharmacol. 2006; 44: 519-525.
25. Towler MC, Hardie DG. AMP-activated protein kinase in metabolic control and insulin signaling. Circ Res. 2007; 100: 328-341.
26. Zou MH, Wu Y. AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol. 2008; 35: 535-545.
27. Wang F, Yan J, Niu Y etal. Mangiferin and its aglycone, norathyriol, improve glucose metabolism by activation of AMP-activated protein kinase. Pharm Biol. 2014; 52: 68-73.
28. Carling D, Sanders MJ, Woods A. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes. 2008; 32: S55-59.
29. Libby P. Inflammation in atherosclerosis. Nature. 2002; 420: 868-874.
30. Yan SD, Schmidt AM, Anderson GM etal. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem. 1994; 269: 9889-9897.
31. Márquez L, García-Bueno B, Madrigal JL, Leza JC. Mangiferin decreases inflammation and oxidative damage in rat brain after stress. Eur J Nutr. 2012; 51: 729-739.
32. Rivera DG, Hernández I, Merino N etal. Mangifera indica L. extract (Vimang) and mangiferin reduce the airway inflammation and Th2 cytokines in murine model of allergic asthma. J Pharm Pharmacol. 2011; 63: 1336-1345.
33. Ahmed N. Advanced glycation endproducts-role in pathology of diabetic complications. Diabetes Res Clin Pract. 2005; 67: 3-21.
34. Zhang FL, Gao HQ, Shen L. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells. J Cardiovasc Pharmacol. 2007; 50: 434-440.
35. Basta G, Lazzerini G, Del Turco S etal. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products. Arterioscler Thromb Vasc Biol. 2005; 25: 1401-1407.